October 11, 2019 – The U.S. Food and Drug Administration (FDA) has approved Quzyttir (cetirizine hydrochloride) injection for the treatment of acute urticaria in adults and children 6 months of age and older. Quzyttir will be available as 10-mg/mL…Original Article
FDA Approves Quzyttir (cetirizine) Injection for the Treatment of Acute Urticaria
